Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex. [electronic resource]
Producer: 20140106Description: 2751-62 p. digitalISSN:- 1532-1827
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Chromosomal Proteins, Non-Histone -- metabolism
- Cyclin-Dependent Kinase 6 -- genetics
- Drug Resistance, Neoplasm -- genetics
- Estradiol -- analogs & derivatives
- Female
- Fulvestrant
- Gene Expression Regulation, Neoplastic
- Histone Deacetylases -- metabolism
- Humans
- Methyltransferases -- metabolism
- Piperazines -- therapeutic use
- Pyridines -- therapeutic use
- Receptors, Estrogen -- genetics
- Receptors, G-Protein-Coupled -- genetics
- Transcription Factors -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.